Quartz Bio

Geneve, Switzerland Founded: 2012 • Age: 14 yrs Acquired By Precision Medicine Group
Biomarker data from clinical trials is analyzed by Quartz Bio.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 11 Brand Intelligence

About Quartz Bio

Quartz Bio is a company based in Geneve (Switzerland) founded in 2012 was acquired by Precision Medicine Group in January 2018. Quartz Bio has completed 1 acquisition, including SolveBio. Quartz Bio offers products and services including Agent Intelligence, Sample Intelligence, and Biomarker Intelligence. Quartz Bio operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

  • Headquarter Geneve, Switzerland
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Precision Medicine Group, Llc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Quartz Bio

Quartz Bio offers a comprehensive portfolio of products and services, including Agent Intelligence, Sample Intelligence, and Biomarker Intelligence.

Product name locked
Category locked
Primary

Delivers 360-degree insights into sample and biomarker data via AI.

Product name locked
Category locked
Locked

Manages clinical trial biospecimens from collection to storage.

Product name locked
Category locked
Locked

Handles biomarker data lifecycle from acquisition to mapping.

People of Quartz Bio

Headcount 1000-5000
Employee Profiles 35
Employee Profiles
People
Karl Deonanan
Chief Financial Officer
People
Kevin Roach
VP Global Operations & Infrastructure
People
Tracey Leahy
Chief People Officer
People
Justin Clavell
Sr. Director Of Business Systems

Unlock access to complete

Funding Insights of Quartz Bio

Premium access

Detailed funding history for Quartz Bio

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Quartz Bio

Quartz Bio has secured backing from 1 investor. Prominent investors backing the company include Precision Medicine Group.

All
Investor Description Founded Year Domain Location
Provider of clinical research, development, and commercialization services for life sciences
Locked Locked Locked
Premium access

Investor details for Quartz Bio

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Quartz Bio

Quartz Bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include SolveBio.

Investments
Premium access

Investment portfolio details for Quartz Bio

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Genomic data analytics platform is provided for precision medicine.
Locked Locked 2013 Locked
Premium access

Complete acquisition details for Quartz Bio

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Quartz Bio

Premium access

Detailed financials for Quartz Bio

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Quartz Bio Comparisons

Quartz Bio Primary company
Description
Biomarker data from clinical trials is analyzed by Quartz Bi...
Location
Geneve, Switzerland
Founded Year
2012
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Quartz Bio

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Quartz Bio

Quartz Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of pharmaceuticals and vaccines for various therapeutic areas
Locked Locked Locked
Antibody-siRNA complexes are developed for cancer treatment.
Locked Locked Locked
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
Locked Locked Locked
Yeast cells are genetically engineered to produce medicinal products.
Locked Locked Locked
Developing novel drugs based on a proteome-wide ligand and target discovery platform
Locked Locked Locked
CRISPR-engineered cell and gene therapies are developed for research applications.
Premium access

Detailed competitors of Quartz Bio

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Quartz Bio

Premium access

Complete news archive for Quartz Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Quartz Bio

Quartz Bio was founded in 2012.

Quartz Bio is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.

Quartz Bio was founded in 2012 in Geneva, Switzerland. Bioinformatics and biostatistics services are delivered to pharmaceutical and diagnostics companies. Biomarker data from clinical trials is processed, from experiment design and statistical analysis planning to patient stratification, visualizations, and reporting. Exploratory data analysis is prioritized, along with experiment design and manuals of operations for large studies to support data collection.

Quartz Bio's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Quartz Bio offers Agent Intelligence, Sample Intelligence, and Biomarker Intelligence.

Quartz Bio has made 1 acquisition, including SolveBio.

Quartz Bio has 1 investor. Key investors include Precision Medicine Group.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available